Compounds > ecopipam
Page last updated: 2024-09-02

ecopipam and Anochlesia

ecopipam has been researched along with Anochlesia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hashimoto, H; Hayashida, M; Hirato, Y; Kasai, A; Niu, M; Seiriki, K; Tanuma, M; Yokoyama, R1
Bergman, J; Rosenzweig-Lipson, S1
Bergman, J; Tidey, JW1
Platt, DM; Rowlett, JK; Spealman, RD1
Hietala, J; Lappalainen, J; Seppäla, T; Syvälahti, E1
Barnett, A; Berger, JG; Chipkin, RE; Coffin, VL; Iorio, LC; McQuade, RD1

Other Studies

6 other study(ies) available for ecopipam and Anochlesia

ArticleYear
Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:3

    Topics: Animals; Benzazepines; Catalepsy; Corpus Striatum; Dopamine Antagonists; Mice, Inbred C57BL; Mice, Transgenic; Prefrontal Cortex; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2

2021
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    European journal of pharmacology, 1994, Aug-01, Volume: 260, Issue:2-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Isoquinolines; Male; Receptors, Dopamine D1; Saimiri; Tetrahydroisoquinolines

1994
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines; Catalepsy; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Methamphetamine; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri

1998
Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Cocaine; Discrimination Learning; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Muscle Rigidity; Receptors, Dopamine D1; Saimiri

2000
Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.
    Psychopharmacology, 1992, Volume: 106, Issue:4

    Topics: Animals; Antipsychotic Agents; Benzazepines; Brain; Catalepsy; Chromatography, Gas; Dopamine Antagonists; In Vitro Techniques; Injections, Subcutaneous; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine D1

1992
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzazepines; Catalepsy; Dogs; Dopamine; Dopamine Antagonists; Homovanillic Acid; Male; Mice; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Vomiting

1988